Drug
Z944 clinical trials
Keep track of what changes. Save the Z944 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStudies by the year they started
3 studies that test it; most in 2020 (1)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Praxis Precision Medicines (3)
Related medicines
As reviewed, each with the page that says it.
- One of Calcium Channel Blockers source
Studies
Open first, then newest update. How each study uses Z944 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)RecruitingPhase 3Praxis Precision MedicinesNCT06087276Written as 60 mg ulixacaltamide
- A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential TremorCompletedPhase 2Praxis Precision MedicinesNCT05021991Written as 100 mg PRAX-944
- A Clinical Trial of PRAX-944 in Participants With Essential TremorCompletedPhase 2Praxis Precision MedicinesNCT05021978Written as Part B: 120 mg PRAX-944
Codes
What other systems call Z944 · ClinicalTrials.gg INT018955
- UNII (FDA) QT2PJH89C3ULIXACALTAMIDEConfirmed FDA, Wikidata
- Wikidata Q27089278Z944Confirmed FDA, Wikidata
- DrugBank DB18788One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | QT2PJH89C3 | ULIXACALTAMIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27089278 | Z944 | Confirmed FDA, Wikidata |
| DrugBank | DB18788 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.